No Data
No Data
Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference
Analysts Are Bullish on Top Healthcare Stocks: Quince Therapeutics (QNCX), Lucid Diagnostics (LUCD)
D. Boral Capital Initiates Quince Therapeutics(QNCX.US) With Buy Rating, Announces Target Price $4
Express News | D. Boral Capital Maintains Buy on Quince Therapeutics, Lowers Price Target to $4
Oppenheimer Initiates Quince Therapeutics(QNCX.US) With Buy Rating, Announces Target Price $10
Express News | Quince Therapeutics Files for Common Stock Offering of up to $21.9 Mln - SEC Filing